Skip to main content

Long Beach Jury Clears J&J In Asbestos Talc Trial

Long Beach Jury Clears J&J In Asbestos Talc Trial

Long Beach Jury Clears J&J In Asbestos Talc Trial

Introduction

On Friday, Oct.11, a California jury freed Johnson & Johnson (J&J) of allegations a plaintiff who claimed that the company's talcum powder contained asbestos, which caused his pleural mesothelioma, a cancer of the lining of the lungs often associated with asbestos exposure.

According to the court documents, the 64-year-old man used J&J baby powder for more than three decades as well as Clubman brand talc powder after haircuts, and he also worked with an auto shop during one summer, where he was exposed to asbestos, which he believed were the reasons for his terminal cancer.

The Long Beach jury, following a nearly three-week trial, rejected the plaintiff's claim that his cancer was caused due to the use of J&J baby powder. J&J was the only defendant when the case went to trial, and it is the second trial in the same week that favored the defendants. Another plaintiff's similar allegation against J&J was also rejected by a California state court jury.

Talcum powder lawsuits are presided by Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J., consolidated under MDL No. 2738.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!